Market News (Page 150) - TendieTensor

Market News Page 150 of 157 • 3,918 articles

4 Dividend Stocks That Keep Paying Through Any Economy

Investing.com • Timothy Fries

4 Dividend Stocks That Keep Paying Through Any Economy

10/28/2025 01:37 PM • The article highlights four dividend stocks that provide stable income and potential growth across different economic conditions, focusing on companies with strong market positions and consistent dividend payouts.

IONQ.WS - Stock has significantly outperformed market average, growing from $1,000 to $3,689 in one year, demonstrating strong potential in quantum computing technology
EIX - Strong infrastructure investment, expanding assets to $50 billion, resilient electric utility with institutional investor support

#dividend stocks #passive income #inflation hedge #utility #consumer products #telecommunications

The Motley Fool • Lee Samaha

Here's Why ATI Stock Flew Higher Today

10/28/2025 01:28 PM • Allegheny Technologies (ATI) reported strong third-quarter earnings and raised full-year guidance, benefiting from improving aerospace supply chain conditions and increased aircraft production expectations.

NVDA - Used as an example of a successful long-term investment that rewards patient investors
ATI - Raised full-year earnings guidance, strong Q3 performance, and positive outlook in aerospace market

#aerospace #materials #supply chain #earnings #guidance

Ken Paxton Alleges Johnson & Johnson Misled Mothers On Tylenol Safety

Benzinga • Vandana Singh

Ken Paxton Alleges Johnson & Johnson Misled Mothers On Tylenol Safety

10/28/2025 01:11 PM • Texas Attorney General Ken Paxton sued Johnson & Johnson and Kenvue, alleging they misled pregnant women about Tylenol's safety by marketing acetaminophen as safe despite research suggesting links to autism and ADHD risks in children.

JNJ - Accused of deceptive marketing, willfully ignoring scientific findings about potential risks of acetaminophen during pregnancy

#Tylenol #lawsuit #pregnancy #acetaminophen #autism #ADHD

Intel: Explosive Comeback Fueled by AI and $15 B Strategic Investments

Investing.com • Itai Smidt

Intel: Explosive Comeback Fueled by AI and $15 B Strategic Investments

10/28/2025 01:06 PM • Intel staged a dramatic turnaround in 2025, rallying over 90% year-to-date with strategic investments from the U.S. government, Nvidia, and SoftBank. The company pivoted towards AI-centric chipmaking, restructured operations, and saw significant financial improvements in Q3 2025.

INTC - Strong Q3 financial performance, 90% stock rally, strategic investments, workforce restructuring, and pivot to AI chip production

#AI #semiconductor #chip production #strategic investment #turnaround

Skyworks Solutions–Qorvo Deal Recasts RF Leader With $500M Synergy Target

Investing.com • Timothy Fries

Skyworks Solutions–Qorvo Deal Recasts RF Leader With $500M Synergy Target

10/28/2025 01:02 PM • Skyworks Solutions and Qorvo announced a transformative merger creating a $22 billion semiconductor company with $7.7 billion in pro forma revenue, targeting $500 million in annual synergies and positioning themselves as a global RF semiconductor leader.

SWKS - Company will lead the merged entity, owns 63% of combined company, sees immediate earnings accretion and significant strategic benefits

#semiconductor #merger #RF technology #synergy #acquisition

Global AI in Medical Diagnostics Market Poised for Phenomenal Expansion at a CAGR of ~22% by 2032 | DelveInsight

GlobeNewswire Inc. • Delveinsight

Global AI in Medical Diagnostics Market Poised for Phenomenal Expansion at a CAGR of ~22% by 2032 | DelveInsight

10/28/2025 01:00 PM • The global AI in medical diagnostics market is projected to grow from $1.6 billion in 2024 to $8 billion by 2032, driven by advances in AI technology, increasing chronic disease prevalence, and demand for precise early diagnostics.

GEHC - Mentioned as a leading company in the AI medical diagnostics market with strong potential for growth

#AI #medical diagnostics #healthcare #machine learning #digital health

GlobeNewswire Inc. • Asm International N.V.

ASM reports third quarter 2025 results

10/28/2025 01:00 PM • ASM International reported Q3 2025 earnings with revenue of €800 million, an 8% year-on-year increase at constant currencies. The company experienced mixed market conditions, with decreased orders from China but strong performance in advanced logic/foundry segments.

DEO - Listed as an official sponsor without specific details about their contribution
ASMVY - Company reported a full reversal of previous impairment of ASMPT stake, reflecting market valuation recovery

#semiconductor #earnings #Q3 2025 #AI #advanced logic #foundry

IPSEN - Buy-back programme - Art 5 of MAR - Week 43 - 2025

GlobeNewswire Inc. • Na

IPSEN - Buy-back programme - Art 5 of MAR - Week 43 - 2025

10/28/2025 01:00 PM • Ipsen reported 12.1% sales growth in the first nine months of 2025 and announced plans to acquire ImCheck Therapeutics to expand its oncology leadership, focusing on the clinical-stage program ICT01 for acute myeloid leukemia.

IPSEY - Strong sales growth of 12.1%, successful performance of key products like Iqirvo®, Bylvay® and Somatuline®, and strategic acquisition of ImCheck Therapeutics to strengthen oncology pipeline

#sales growth #oncology #acquisition #clinical trials #pharmaceutical

IPSEN - Achats effectués dans les conditions de l'Article 5 du Règlement MAR - Semaine 43 - 2025

GlobeNewswire Inc. • Na

IPSEN - Achats effectués dans les conditions de l'Article 5 du Règlement MAR - Semaine 43 - 2025

10/28/2025 01:00 PM • Ipsen reported strong sales growth of 12.1% year-to-date and announced plans to acquire ImCheck Therapeutics to expand its oncology leadership, focusing on a clinical-stage program in acute myeloid leukemia.

DEO - Mentioned as a campaign sponsor with no specific context about their involvement
IPSEY - Strong sales performance, strategic acquisition, and expansion of oncology pipeline indicate positive business momentum

#sales growth #oncology #acquisition #clinical trials

Honeywell Bets On Farm Waste To Power Planes And Ships More Sustainably

Benzinga • Akanksha Bakshi

Honeywell Bets On Farm Waste To Power Planes And Ships More Sustainably

10/28/2025 12:36 PM • Honeywell International introduced a new technology converting agricultural and forestry waste into renewable fuels for shipping and aviation, offering a sustainable alternative to traditional heavy fuel oil with lower carbon emissions.

HON - The company is innovating in sustainable technology, developing a modular biocrude upgrading process that can convert waste into renewable fuels, potentially reducing emissions and creating new market opportunities

#renewable fuels #biomass #sustainable aviation #maritime industry #decarbonization

Independent Bank (IBCP) Earnings Transcript

The Motley Fool • Motley Fool Transcribing

Independent Bank (IBCP) Earnings Transcript

10/28/2025 12:27 PM • Independent Bank reported strong municipal deposit growth, stable net interest margin, and minimal credit concerns in Q3 2025. The bank added three experienced commercial bankers in Southeast Michigan and maintained an optimistic outlook on future asset repricing.

BITY - Substantial distribution of $1.10159 per share suggests consistent income performance
IBCP - Positive indicators include strong deposit growth, stable net interest margin, strategic commercial banking hires, low credit watch list, and management's optimistic outlook about future asset repricing and Michigan's economic stability

#banking #earnings #deposits #commercial banking #Michigan economy

Visa Earnings Preview: Can the Momentum Last Without Margin Squeeze?

Investing.com • Ali Merchant

Visa Earnings Preview: Can the Momentum Last Without Margin Squeeze?

10/28/2025 12:25 PM • Visa is preparing to report Q4 FY'25 earnings, with analysts expecting strong revenue growth driven by robust payment volumes and cross-border transactions. The key focus is on maintaining momentum without margin compression amid mixed economic signals.

SLJY - Moderate distribution of $0.46500 per share indicates stable but not exceptional performance
V - Strong financial performance with 14% YoY revenue growth, 8% payment volume increase, consistent earnings, 17 years of dividend raises, and positive analyst upgrades from Citi and Wells Fargo

#earnings #payments #fintech #cross-border transactions #digital commerce

Qorvo, Skyworks Strike $22B Merger To Tackle Next-Gen Connectivity

Benzinga • Lekha Gupta

Qorvo, Skyworks Strike $22B Merger To Tackle Next-Gen Connectivity

10/28/2025 12:22 PM • Qorvo and Skyworks announced a $22 billion merger to create a combined entity with $7.7 billion in pro forma revenue, targeting next-generation connectivity and diversified markets like defense, aerospace, and automotive.

QRVO - Company is merging with Skyworks, expected to generate significant synergies, and reported strong preliminary Q2 results with $1.1 billion revenue

#merger #connectivity #semiconductor #RF technology #next-gen

Noble (NE) Q3 2025 Earnings Call Transcript

The Motley Fool • Motley Fool Transcribing

Noble (NE) Q3 2025 Earnings Call Transcript

10/28/2025 12:21 PM • Noble Corporation reported Q3 2025 earnings with $254 million adjusted EBITDA and $139 million free cash flow. Management expects EBITDA to trough in 2026 but anticipates market recovery in late 2026, driven by increasing deepwater exploration demand and strategic contract positioning.

NE - Mixed outlook with current market challenges but optimistic about future deepwater market tightening and potential contract opportunities in late 2026

#offshore drilling #deepwater exploration #earnings call #EBITDA #market recovery

T. ROWE PRICE GROUP, INC., DECLARES QUARTERLY DIVIDEND

Benzinga • Prnewswire

T. ROWE PRICE GROUP, INC., DECLARES QUARTERLY DIVIDEND

10/28/2025 12:20 PM • T. Rowe Price Group announced a quarterly dividend of $1.27 per share, payable on December 30, 2025, to stockholders of record as of December 15, 2025. The global asset management firm manages $1.77 trillion in client assets.

TROW - Company demonstrates financial stability by declaring a consistent quarterly dividend and highlights strong asset management performance with $1.77 trillion in client assets

#dividend #asset management #quarterly dividend #retirement

Thames Capital Bets Big On Cipher Mining (CIFR) and Its Bitcoin Mining Peers

The Motley Fool • Cory Renauer

Thames Capital Bets Big On Cipher Mining (CIFR) and Its Bitcoin Mining Peers

10/28/2025 12:13 PM • Thames Capital Management LLC acquired 1,514,664 shares of Cipher Mining during Q3 2025, valued at approximately $19.07 million, representing 2.72% of their reportable assets. The investment appears strategic, potentially anticipating increased demand from AI applications requiring significant energy and processing power.

RSG - Expanding RNG fueling portfolio with new stations in Colorado and Nevada, adding new trucks and fueling capacity
CIFR - Strong stock performance (+262.90% over past year), new AI cloud platform deal worth potentially $7 billion, and growing institutional investor interest

#bitcoin mining #cryptocurrency #AI infrastructure #institutional investment

If You'd Invested $100 in RGTI Stock 1 Year Ago, Here's How Much You'd Have Today

The Motley Fool • Thomas Niel

If You'd Invested $100 in RGTI Stock 1 Year Ago, Here's How Much You'd Have Today

10/28/2025 12:10 PM • Rigetti Computing's stock surged over 33x in the past year, turning a $100 investment into $3,369, driven by breakthroughs in quantum computing and the company's progress towards commercialization.

RGTI - Stock price increased 33x in one year, company is moving into revenue stage, securing new orders for quantum computing systems, and showing potential for future growth

#quantum computing #stock investment #technology stocks #RGTI

Law Offices of Frank R. Cruz Encourages MoonLake Immunotherapeutics (MLTX) Shareholders to Inquire About Securities Fraud Class Action

Benzinga • Business Wire

Law Offices of Frank R. Cruz Encourages MoonLake Immunotherapeutics (MLTX) Shareholders to Inquire About Securities Fraud Class Action

10/28/2025 12:03 PM • MoonLake Immunotherapeutics experienced a significant stock drop after announcing disappointing Phase 3 results for its drug candidate sonelokimab, which failed to match competitor's drug efficacy, leading to a potential securities fraud class action lawsuit.

MSFT - Mentioned as a participant providing insights on AI's role in insurance landscape
MLTX - Stock dropped 89.9% after revealing ineffective drug trial results, potential misrepresentation of drug capabilities, and facing a class action lawsuit

#securities fraud #class action #Phase 3 results #drug development #stock drop